They made headlines worldwide. Cure for hepc! the issue is if you look at the results, it was a very small trial. 12 people started and nearly 40% dropped out due to adverse reactions to the cocktail of drugs (bit225 was 1/3). Question - is a 40% drop out, a successful trial?
Of course, the price pumped. Whilst,the punters excitedly awaited further results and dreaming of 30 b deals, there was a large director sell and 11 years later, no deal!
Sound familiar... you bet ya!
#strongerrulesforbiosnow
BIT Price at posting:
2.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)